Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Trading Statement and Board update

26 Jan 2021 07:00

RNS Number : 8352M
Anpario PLC
26 January 2021
 

 

Anpario plc

("Anpario" or the "Group")

 

Trading Statement and Board update

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2020.

 

The Group has delivered a very strong operating performance despite a very difficult year around the world due to the pandemic. Full year sales are now expected to be not less than £30m and profit to be well ahead of expectations. This performance is reflected in the Group's strong cash generation with year-end cash balances of £15.8m (31 Dec 2019 £13.8m) after a £1m buyback programme and in addition to increased dividend distributions.

 

There were strong performances in the Americas, Europe and in China where sales showed a strong recovery as farmers restocked their pig operations and the ban on the use of anti-biotic growth promoters (AGPs) in animal feed benefited sales of Orego-Stim®. The Middle East experienced continued weakness in the second half. The strongest growth was experienced in our subsidiaries where local sales teams were able to fully support customers throughout the pandemic.

 

The Board would like to thank all stakeholders, especially our staff around the world, who have adapted to new ways of working and put every effort into ensuring continued production and delivery of our products to customers and our subsidiaries around the world.

 

Board update

 

Richard Wood has given notice to Anpario that he will retire as Non-Executive Director, Senior Independent Director and Chair of the Remuneration Committee with effect from 31 March 2021. Peter Lawrence has informed Anpario that he will retire as Non-Executive Chairman, Chair of the Audit and Nomination committees at Anpario's AGM on 17 June 2021. Anpario recently announced two new Non-Executive Directors, Matthew Robinson and Kate Allum. A further announcement will be made regarding the positions of Senior Independent Director and Chairman.

 

Richard Edwards, Chief Executive, commented; "I would personally, and on behalf of the Board, like to take this opportunity to thank Peter and Richard for their contribution, commitment and invaluable guidance and support to both Karen and me during their time on the Board in the development of Anpario."

 

The Group expects to announce its preliminary results for the year ended 31 December 2020 on 17 March 2021.

 

Anpario has released a corporate video which can be viewed at:

https://www.anpario.com/investor/aim-26/

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

Anpario plc

Richard Edwards, CEO

+44(0) 7776 417129

Karen Prior, Group Finance Director

+44(0) 1909 537380

Peel Hunt LLP (NOMAD)

+44(0) 2074 188900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDBCDDDGBU
Date   Source Headline
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update
25th Jan 20217:00 amRNSDirectorate Change
18th Jan 20217:00 amBUSBlock listing Interim Review
8th Jan 20217:00 amBUSDirectorate change
9th Dec 202010:55 amBUSTotal Voting Rights
5th Nov 20205:03 pmBUSDirector/PDMR Shareholding
3rd Nov 202010:06 amRNSTotal Voting Rights
16th Oct 20201:22 pmRNSLady Oregon Goes Aloft
9th Oct 20207:17 amRNSDirector/PDMR Shareholding
2nd Oct 202012:13 pmRNSTotal Voting Rights
24th Sep 20207:00 amRNSChange of auditor
18th Sep 20204:24 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amBUSHalf-year Report
17th Jul 202010:55 amRNSBlock listing Interim Review
7th Jul 20201:43 pmRNSTotal Voting Rights
3rd Jul 20203:42 pmRNSHolding(s) in Company
3rd Jul 20202:42 pmRNSHolding(s) in Company
25th Jun 20202:13 pmRNSResult of the AGM
25th Jun 20207:00 amRNSAGM Statement
18th Jun 20205:06 pmRNSHolding(s) in Company
1st May 20205:43 pmBUSNotice of AGM
1st May 202010:16 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCOVID-19 Update and Patent Application
7th Apr 20208:45 amRNSTotal Voting Rights
18th Mar 20207:00 amBUSFinal Results
13th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSCompletion of Buyback Programme
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
24th Feb 20207:00 amRNSTransaction in Own Shares
20th Feb 20203:11 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSTransaction in Own Shares
12th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20203:31 pmRNSHolding(s) in Company
7th Feb 202011:16 amRNSHolding(s) in Company
7th Feb 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.